CASP3 and neoplasm: Further work by ourselves adopted AT-MSCs which were transduced with TRAIL and definitely promoted apoptosis in U-266 cells by the caspase-3 activation [30] in a similar manner as for other tumor models using these engineered MSCs [31–34].